NO20091016L - Pyridooksazepin-progesteron reseptormodulatorer - Google Patents
Pyridooksazepin-progesteron reseptormodulatorerInfo
- Publication number
- NO20091016L NO20091016L NO20091016A NO20091016A NO20091016L NO 20091016 L NO20091016 L NO 20091016L NO 20091016 A NO20091016 A NO 20091016A NO 20091016 A NO20091016 A NO 20091016A NO 20091016 L NO20091016 L NO 20091016L
- Authority
- NO
- Norway
- Prior art keywords
- receptor modulators
- progesterone receptor
- pyridooksazepine
- fluorodibenzo
- oxazepine
- Prior art date
Links
- 239000002379 progesterone receptor modulator Substances 0.000 title abstract 2
- 229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06121372 | 2006-09-27 | ||
| PCT/EP2007/060225 WO2008037746A1 (fr) | 2006-09-27 | 2007-09-26 | Modulateurs des récepteurs de la progestérone de type pyridooxazépine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091016L true NO20091016L (no) | 2009-03-30 |
Family
ID=37813577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091016A NO20091016L (no) | 2006-09-27 | 2009-03-06 | Pyridooksazepin-progesteron reseptormodulatorer |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP2066677B1 (fr) |
| JP (1) | JP2010504943A (fr) |
| KR (1) | KR20090064454A (fr) |
| CN (1) | CN101522689B (fr) |
| AR (1) | AR063018A1 (fr) |
| AT (1) | ATE478078T1 (fr) |
| AU (1) | AU2007302007B2 (fr) |
| BR (1) | BRPI0716830A2 (fr) |
| CA (1) | CA2664120A1 (fr) |
| CL (1) | CL2007002788A1 (fr) |
| CO (1) | CO6160325A2 (fr) |
| CY (1) | CY1110846T1 (fr) |
| DE (1) | DE602007008589D1 (fr) |
| DK (1) | DK2066677T3 (fr) |
| ES (1) | ES2349325T3 (fr) |
| HR (1) | HRP20100526T1 (fr) |
| IL (1) | IL197365A0 (fr) |
| MX (1) | MX2009002804A (fr) |
| NO (1) | NO20091016L (fr) |
| NZ (1) | NZ575276A (fr) |
| PE (1) | PE20071451A1 (fr) |
| PL (1) | PL2066677T3 (fr) |
| PT (1) | PT2066677E (fr) |
| RU (1) | RU2009115643A (fr) |
| SI (1) | SI2066677T1 (fr) |
| TW (1) | TW200820975A (fr) |
| WO (1) | WO2008037746A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI297685B (en) | 2002-04-04 | 2008-06-11 | Organon Nv | Non-steroidal progesterone receptor modulators |
| CN101200429B (zh) * | 2006-12-13 | 2012-08-22 | 上海睿智化学研究有限公司 | 2-硝基-4,5-二卤代苯酚类和2-氨基-4,5-二卤代苯酚类及其盐及其合成方法 |
| US8063037B2 (en) | 2007-05-07 | 2011-11-22 | N. V. Organon | Progesterone receptor modulators |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004508373A (ja) * | 2000-09-07 | 2004-03-18 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 環式および非環式アミジンおよびプロゲステロン受容体結合剤として使用するためのそれらを含有する医薬組成物 |
| TWI297685B (en) * | 2002-04-04 | 2008-06-11 | Organon Nv | Non-steroidal progesterone receptor modulators |
-
2007
- 2007-09-26 CA CA002664120A patent/CA2664120A1/fr not_active Abandoned
- 2007-09-26 NZ NZ575276A patent/NZ575276A/en unknown
- 2007-09-26 MX MX2009002804A patent/MX2009002804A/es not_active Application Discontinuation
- 2007-09-26 PL PL07820620T patent/PL2066677T3/pl unknown
- 2007-09-26 JP JP2009529699A patent/JP2010504943A/ja not_active Ceased
- 2007-09-26 EP EP07820620A patent/EP2066677B1/fr active Active
- 2007-09-26 HR HR20100526T patent/HRP20100526T1/hr unknown
- 2007-09-26 AT AT07820620T patent/ATE478078T1/de active
- 2007-09-26 PT PT07820620T patent/PT2066677E/pt unknown
- 2007-09-26 KR KR1020097007645A patent/KR20090064454A/ko not_active Withdrawn
- 2007-09-26 RU RU2009115643/04A patent/RU2009115643A/ru not_active Application Discontinuation
- 2007-09-26 TW TW096135743A patent/TW200820975A/zh unknown
- 2007-09-26 DE DE602007008589T patent/DE602007008589D1/de active Active
- 2007-09-26 ES ES07820620T patent/ES2349325T3/es active Active
- 2007-09-26 CN CN2007800361667A patent/CN101522689B/zh not_active Expired - Fee Related
- 2007-09-26 BR BRPI0716830-6A patent/BRPI0716830A2/pt not_active IP Right Cessation
- 2007-09-26 WO PCT/EP2007/060225 patent/WO2008037746A1/fr not_active Ceased
- 2007-09-26 SI SI200730404T patent/SI2066677T1/sl unknown
- 2007-09-26 DK DK07820620.8T patent/DK2066677T3/da active
- 2007-09-26 AU AU2007302007A patent/AU2007302007B2/en not_active Ceased
- 2007-09-27 PE PE2007001315A patent/PE20071451A1/es not_active Application Discontinuation
- 2007-09-27 CL CL200702788A patent/CL2007002788A1/es unknown
- 2007-09-27 AR ARP070104267A patent/AR063018A1/es not_active Application Discontinuation
-
2009
- 2009-03-03 IL IL197365A patent/IL197365A0/en unknown
- 2009-03-06 NO NO20091016A patent/NO20091016L/no not_active Application Discontinuation
- 2009-03-27 CO CO09031994A patent/CO6160325A2/es unknown
-
2010
- 2010-10-21 CY CY20101100942T patent/CY1110846T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007302007A1 (en) | 2008-04-03 |
| PE20071451A1 (es) | 2008-10-30 |
| JP2010504943A (ja) | 2010-02-18 |
| CN101522689B (zh) | 2012-01-11 |
| TW200820975A (en) | 2008-05-16 |
| EP2066677A1 (fr) | 2009-06-10 |
| CL2007002788A1 (es) | 2008-04-18 |
| PT2066677E (pt) | 2010-11-10 |
| DE602007008589D1 (de) | 2010-09-30 |
| MX2009002804A (es) | 2009-03-31 |
| CN101522689A (zh) | 2009-09-02 |
| BRPI0716830A2 (pt) | 2013-11-05 |
| CY1110846T1 (el) | 2015-06-10 |
| CO6160325A2 (es) | 2010-05-20 |
| AR063018A1 (es) | 2008-12-23 |
| HRP20100526T1 (hr) | 2010-11-30 |
| KR20090064454A (ko) | 2009-06-18 |
| AU2007302007B2 (en) | 2012-02-02 |
| ATE478078T1 (de) | 2010-09-15 |
| RU2009115643A (ru) | 2010-11-10 |
| PL2066677T3 (pl) | 2011-02-28 |
| HK1126767A1 (en) | 2009-09-11 |
| SI2066677T1 (sl) | 2010-12-31 |
| IL197365A0 (en) | 2009-12-24 |
| NZ575276A (en) | 2011-07-29 |
| DK2066677T3 (da) | 2010-11-08 |
| ES2349325T3 (es) | 2010-12-30 |
| CA2664120A1 (fr) | 2008-04-03 |
| EP2066677B1 (fr) | 2010-08-18 |
| WO2008037746A1 (fr) | 2008-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
| NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
| EA200900781A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды | |
| ATE473744T1 (de) | Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren | |
| EA200801758A1 (ru) | Лекарственные формы, устойчивые к самовольному изменению | |
| DK1833799T3 (da) | 3-phenyl-pyrazol derivater, som modulatorer af 5-HT-2a-serotonin receptor nyttig til behandlingen af sygdomme relateret hertil | |
| NO20093146L (no) | Amino-pyridinderivater som S1P1/EDG1-reseptoragonister | |
| MX2010002028A (es) | Metodos y composiciones para modular celulas t. | |
| WO2009012275A9 (fr) | Agonistes du récepteur gpr119 couplé à la protéine g pyridone | |
| MX2010004374A (es) | Armazones proteinicos. | |
| DK1928845T3 (da) | Aminodiazepiner som toll-lignende receptor-modulatorer | |
| DK3093291T3 (da) | Disubstituerede octahy-dropyrrolo [3,4-c]pyrroler som orexinreceptormodulatorer | |
| NO20091395L (no) | Nye tiofenderivater | |
| DK1984345T3 (da) | Benzoxaziner og beslægtede nitrogenholdige heterobicykliske forbindelser, der kan anvendes som mineralcorticoidreceptormodulerende midler | |
| CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
| UA104438C2 (uk) | Спосіб одержання дабігатрану і його проміжних сполук | |
| DK2238110T3 (da) | 5.6-bisaryl-2-pyridin-carboxamid-derivater, fremstilling heraf og terapeutisk anvendelse heraf som urotensin II-receptorantagonister | |
| NO20070379L (no) | Kjemiske forbindelser | |
| EA201000258A1 (ru) | Новые гербициды | |
| NO344044B1 (no) | Nye triazindionderivater som GABA-B-reseptormodulatorer | |
| NO20083593L (no) | Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse | |
| MX2009007336A (es) | Indazoles substituidos con 5-furopiridinona. | |
| DK2094684T3 (da) | 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-on som CB1-receptor modulatorer | |
| EA200800713A1 (ru) | Аморфные твёрдые дисперсии | |
| MX2009010288A (es) | Dispositivo para la administracion de composiciones viscosas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |